| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 7.95e-07 | 38 | 171 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.15e-05 | 35 | 171 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | peptidase activity | PRSS54 USP34 ADAM23 ADAM9 PSMB5 PSMB8 ERMP1 DPP8 ATG4B APH1A ADAMTS9 OTUD6B PCSK7 PAPPA USP48 AGBL1 | 1.64e-04 | 654 | 171 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.69e-04 | 230 | 171 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 3.55e-04 | 153 | 171 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.40e-04 | 118 | 171 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | retinoid binding | 7.53e-04 | 48 | 171 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | actin filament binding | 7.75e-04 | 227 | 171 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 8.15e-04 | 49 | 171 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | B3GNT5 UGT1A6 UGGT1 PPAT PARP4 UGT2B4 UGT2B7 UGT2B28 UGT2B11 | 8.67e-04 | 288 | 171 | 9 | GO:0016757 |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 3.18e-07 | 8 | 172 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 6.95e-07 | 21 | 172 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 9.43e-07 | 10 | 172 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.17e-06 | 26 | 172 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.17e-06 | 26 | 172 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.19e-06 | 12 | 172 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization | 5.93e-06 | 15 | 172 | 4 | GO:0031115 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.34e-05 | 37 | 172 | 5 | GO:0042537 | |
| GeneOntologyBiologicalProcess | protein catabolic process | AZIN2 ADAM9 UGGT1 UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 PCYOX1L CDK5RAP3 ATG4B FBXO10 NFE2L1 CHEK2 LRP2 PAPPA HERC2 SYVN1 KLHDC10 EIF2A CDC27 | 1.89e-05 | 1115 | 172 | 24 | GO:0030163 |
| GeneOntologyBiologicalProcess | retina layer formation | 5.15e-05 | 25 | 172 | 4 | GO:0010842 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | UGGT1 UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 PCYOX1L CDK5RAP3 FBXO10 NFE2L1 HERC2 SYVN1 KLHDC10 EIF2A CDC27 | 1.57e-04 | 812 | 172 | 18 | GO:0051603 |
| GeneOntologyCellularComponent | muscle myosin complex | 7.81e-06 | 16 | 174 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 9.54e-06 | 59 | 174 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 5.12e-05 | 25 | 174 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 8.12e-05 | 28 | 174 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.35e-04 | 40 | 174 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | basement membrane | 5.56e-04 | 122 | 174 | 6 | GO:0005604 | |
| Domain | Gal_Oxidase_b-propeller | 5.47e-07 | 34 | 169 | 6 | IPR015916 | |
| Domain | UDPGT | 1.03e-06 | 21 | 169 | 5 | PF00201 | |
| Domain | UDPGT | 1.03e-06 | 21 | 169 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 1.03e-06 | 21 | 169 | 5 | IPR002213 | |
| Domain | Myosin_head_motor_dom | 1.09e-06 | 38 | 169 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.09e-06 | 38 | 169 | 6 | PS51456 | |
| Domain | Myosin_head | 1.09e-06 | 38 | 169 | 6 | PF00063 | |
| Domain | MYSc | 1.09e-06 | 38 | 169 | 6 | SM00242 | |
| Domain | EGF_1 | ADAM23 ADAM9 FAT3 CRB1 CELSR1 TNN LRP2 ASTN2 C7 C8B USH2A AGRN | 3.70e-06 | 255 | 169 | 12 | PS00022 |
| Domain | - | 3.93e-06 | 27 | 169 | 5 | 2.130.10.80 | |
| Domain | Myosin_N | 8.17e-06 | 15 | 169 | 4 | PF02736 | |
| Domain | Myosin_N | 8.17e-06 | 15 | 169 | 4 | IPR004009 | |
| Domain | EGF_3 | 1.00e-05 | 235 | 169 | 11 | PS50026 | |
| Domain | VWA | 1.12e-05 | 56 | 169 | 6 | PF00092 | |
| Domain | Laminin_G | 1.38e-05 | 58 | 169 | 6 | IPR001791 | |
| Domain | Kelch | 1.38e-05 | 58 | 169 | 6 | SM00612 | |
| Domain | HELP | 1.43e-05 | 6 | 169 | 3 | PF03451 | |
| Domain | HELP | 1.43e-05 | 6 | 169 | 3 | IPR005108 | |
| Domain | Myosin_tail_1 | 1.79e-05 | 18 | 169 | 4 | PF01576 | |
| Domain | Myosin_tail | 1.79e-05 | 18 | 169 | 4 | IPR002928 | |
| Domain | LAM_G_DOMAIN | 2.25e-05 | 38 | 169 | 5 | PS50025 | |
| Domain | Myosin-like_IQ_dom | 2.26e-05 | 19 | 169 | 4 | IPR027401 | |
| Domain | - | 2.26e-05 | 19 | 169 | 4 | 4.10.270.10 | |
| Domain | EGF_2 | 3.05e-05 | 265 | 169 | 11 | PS01186 | |
| Domain | Kelch_1 | 4.08e-05 | 70 | 169 | 6 | PF01344 | |
| Domain | Kelch_1 | 4.08e-05 | 70 | 169 | 6 | IPR006652 | |
| Domain | BTB-kelch_protein | 4.17e-05 | 43 | 169 | 5 | IPR017096 | |
| Domain | IQ | 4.42e-05 | 71 | 169 | 6 | PF00612 | |
| Domain | LamG | 4.67e-05 | 44 | 169 | 5 | SM00282 | |
| Domain | - | 5.59e-05 | 74 | 169 | 6 | 3.40.50.410 | |
| Domain | NosD | 8.14e-05 | 2 | 169 | 2 | PF05048 | |
| Domain | Para_beta_helix_rpt-2 | 8.14e-05 | 2 | 169 | 2 | IPR022441 | |
| Domain | NosD_dom | 8.14e-05 | 2 | 169 | 2 | IPR007742 | |
| Domain | EGF-like_dom | 9.27e-05 | 249 | 169 | 10 | IPR000742 | |
| Domain | IQ | 9.30e-05 | 81 | 169 | 6 | SM00015 | |
| Domain | VWFA | 9.96e-05 | 82 | 169 | 6 | PS50234 | |
| Domain | MACPF | 1.14e-04 | 11 | 169 | 3 | PF01823 | |
| Domain | VWA | 1.14e-04 | 84 | 169 | 6 | SM00327 | |
| Domain | EGF-like_CS | 1.36e-04 | 261 | 169 | 10 | IPR013032 | |
| Domain | MACPF | 1.51e-04 | 12 | 169 | 3 | IPR020864 | |
| Domain | MACPF | 1.51e-04 | 12 | 169 | 3 | SM00457 | |
| Domain | IQ_motif_EF-hand-BS | 1.67e-04 | 90 | 169 | 6 | IPR000048 | |
| Domain | ConA-like_dom | 1.76e-04 | 219 | 169 | 9 | IPR013320 | |
| Domain | BTB | 1.91e-04 | 131 | 169 | 7 | PF00651 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.93e-04 | 59 | 169 | 5 | IPR011043 | |
| Domain | IQ | 2.00e-04 | 93 | 169 | 6 | PS50096 | |
| Domain | BACK | 2.09e-04 | 60 | 169 | 5 | SM00875 | |
| Domain | - | 2.24e-04 | 95 | 169 | 6 | 2.60.120.200 | |
| Domain | BACK | 2.26e-04 | 61 | 169 | 5 | IPR011705 | |
| Domain | BACK | 2.26e-04 | 61 | 169 | 5 | PF07707 | |
| Domain | CASH | 2.43e-04 | 3 | 169 | 2 | SM00722 | |
| Domain | Carb-bd_sugar_hydrolysis-dom | 2.43e-04 | 3 | 169 | 2 | IPR006633 | |
| Domain | VWF_A | 2.81e-04 | 99 | 169 | 6 | IPR002035 | |
| Domain | GPS | 3.04e-04 | 36 | 169 | 4 | PS50221 | |
| Domain | GPS | 3.38e-04 | 37 | 169 | 4 | IPR000203 | |
| Domain | Laminin_G_2 | 4.59e-04 | 40 | 169 | 4 | PF02210 | |
| Domain | FacI_MAC | 4.83e-04 | 4 | 169 | 2 | IPR003884 | |
| Domain | LamGL | 4.83e-04 | 4 | 169 | 2 | SM00560 | |
| Domain | LamG-like | 4.83e-04 | 4 | 169 | 2 | IPR006558 | |
| Domain | FIMAC | 4.83e-04 | 4 | 169 | 2 | SM00057 | |
| Domain | BTB | 6.42e-04 | 160 | 169 | 7 | PS50097 | |
| Domain | Cadherin | 7.18e-04 | 118 | 169 | 6 | IPR002126 | |
| Domain | RCC1 | 7.41e-04 | 20 | 169 | 3 | PF00415 | |
| Domain | VWA_N | 8.00e-04 | 5 | 169 | 2 | IPR013608 | |
| Domain | VWA_N | 8.00e-04 | 5 | 169 | 2 | PF08399 | |
| Domain | RCC1_1 | 8.59e-04 | 21 | 169 | 3 | PS00625 | |
| Domain | RCC1_2 | 8.59e-04 | 21 | 169 | 3 | PS00626 | |
| Domain | RCC1_3 | 8.59e-04 | 21 | 169 | 3 | PS50012 | |
| Domain | - | 9.88e-04 | 22 | 169 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 9.88e-04 | 22 | 169 | 3 | IPR000408 | |
| Domain | WD_REPEATS_1 | 9.91e-04 | 278 | 169 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.02e-03 | 279 | 169 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.02e-03 | 279 | 169 | 9 | PS50294 | |
| Domain | RCC1/BLIP-II | 1.13e-03 | 23 | 169 | 3 | IPR009091 | |
| Domain | Pectin_lyas_fold | 1.19e-03 | 6 | 169 | 2 | IPR012334 | |
| Domain | PbH1 | 1.19e-03 | 6 | 169 | 2 | SM00710 | |
| Domain | - | 1.19e-03 | 6 | 169 | 2 | 2.160.20.10 | |
| Domain | MACPF_CS | 1.19e-03 | 6 | 169 | 2 | IPR020863 | |
| Domain | Lipase_euk | 1.19e-03 | 6 | 169 | 2 | IPR025483 | |
| Domain | Abhydro_lipase | 1.19e-03 | 6 | 169 | 2 | PF04083 | |
| Domain | AB_hydrolase_lipase | 1.19e-03 | 6 | 169 | 2 | IPR006693 | |
| Domain | PbH1 | 1.19e-03 | 6 | 169 | 2 | IPR006626 | |
| Domain | BTB | 1.28e-03 | 180 | 169 | 7 | SM00225 | |
| Domain | - | 1.28e-03 | 24 | 169 | 3 | 3.60.20.10 | |
| Domain | EGF | 1.37e-03 | 235 | 169 | 8 | SM00181 | |
| Domain | BTB/POZ_dom | 1.50e-03 | 185 | 169 | 7 | IPR000210 | |
| Domain | WD40_repeat_dom | 1.57e-03 | 297 | 169 | 9 | IPR017986 | |
| Domain | MACPF_2 | 1.66e-03 | 7 | 169 | 2 | PS51412 | |
| Domain | MACPF_1 | 1.66e-03 | 7 | 169 | 2 | PS00279 | |
| Domain | ZnF_UBR1 | 1.66e-03 | 7 | 169 | 2 | SM00396 | |
| Domain | Myosin_TH1 | 1.66e-03 | 7 | 169 | 2 | PF06017 | |
| Domain | ZF_UBR | 1.66e-03 | 7 | 169 | 2 | PS51157 | |
| Domain | Myosin_TH1 | 1.66e-03 | 7 | 169 | 2 | IPR010926 | |
| Domain | zf-UBR | 1.66e-03 | 7 | 169 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.66e-03 | 7 | 169 | 2 | IPR003126 | |
| Domain | TH1 | 1.66e-03 | 7 | 169 | 2 | PS51757 | |
| Domain | SKP1/BTB/POZ | 1.69e-03 | 189 | 169 | 7 | IPR011333 | |
| Domain | EGF_extracell | 2.13e-03 | 60 | 169 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.13e-03 | 60 | 169 | 4 | PF07974 | |
| Domain | Pectin_lyase_fold/virulence | 2.20e-03 | 8 | 169 | 2 | IPR011050 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.30e-06 | 41 | 122 | 6 | M7399 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.07e-06 | 25 | 122 | 5 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.07e-06 | 25 | 122 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.54e-06 | 26 | 122 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.75e-06 | 28 | 122 | 5 | M19580 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.86e-06 | 51 | 122 | 6 | M17726 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.71e-05 | 44 | 122 | 5 | M45014 | |
| Pathway | REACTOME_PREDNISONE_ADME | 4.16e-05 | 23 | 122 | 4 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.96e-05 | 24 | 122 | 4 | MM14599 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 FBXO10 HERC2 CDC27 | 5.65e-05 | 299 | 122 | 11 | MM15711 |
| Pathway | WP_GLUCURONIDATION | 5.87e-05 | 25 | 122 | 4 | MM15820 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 FBXO10 HERC2 CDC27 | 7.38e-05 | 308 | 122 | 11 | M1070 |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.39e-05 | 52 | 122 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.10e-04 | 55 | 122 | 5 | M14933 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 FBXO10 HERC2 CDC27 | 1.90e-04 | 343 | 122 | 11 | MM15712 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.15e-04 | 14 | 122 | 3 | M39328 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.27e-04 | 64 | 122 | 5 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.45e-04 | 70 | 122 | 5 | M16794 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.47e-04 | 39 | 122 | 4 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | 3.64e-04 | 109 | 122 | 6 | M45012 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.94e-04 | 72 | 122 | 5 | M9257 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.22e-04 | 41 | 122 | 4 | MM15538 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | AKT3 COL17A1 UBR4 PSMB5 PSMB8 FBXW4 XDH FBXO11 KEAP1 HUWE1 KLHL20 FBXO10 ICOS HERC2 CDC27 MAP3K7 | 4.66e-04 | 719 | 122 | 16 | MM14540 |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBR4 PSMB5 PSMB8 FBXW4 FBXO11 KEAP1 HUWE1 KLHL20 FBXO10 HERC2 CDC27 | 4.67e-04 | 381 | 122 | 11 | M1066 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.55e-04 | 44 | 122 | 4 | M27812 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.05e-04 | 45 | 122 | 4 | MM15694 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.01e-09 | 5 | 174 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.01e-09 | 5 | 174 | 4 | 12919077 | |
| Pubmed | 3.01e-09 | 5 | 174 | 4 | 6196357 | ||
| Pubmed | 9.01e-09 | 6 | 174 | 4 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 9.01e-09 | 6 | 174 | 4 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 9.01e-09 | 6 | 174 | 4 | 10588881 | |
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 26074487 | ||
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 35210422 | ||
| Pubmed | 2.09e-08 | 7 | 174 | 4 | 16819597 | ||
| Pubmed | KLHL28 UBR4 LMTK2 KEAP1 HUWE1 PPM1B CLPB EBP LRP2 HERC2 KLHDC10 CDC27 MAP3K7 USP48 AGRN | 2.34e-08 | 481 | 174 | 15 | 28190767 | |
| Pubmed | 4.17e-08 | 8 | 174 | 4 | 32093886 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.23e-07 | 3 | 174 | 3 | 26059207 | |
| Pubmed | AKT3 RIOK1 KLHL28 SGK1 ATP8A2 ADAM9 KEAP1 DPP8 PLXNB2 KLHL20 PPM1B SGK3 NFE2L1 LRP2 PCSK7 TAF5L KLHL17 | 1.79e-07 | 730 | 174 | 17 | 34857952 | |
| Pubmed | 1.94e-07 | 11 | 174 | 4 | 8136524 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 4.18e-07 | 13 | 174 | 4 | 8404542 | |
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 20357587 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 4.91e-07 | 4 | 174 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 4.91e-07 | 4 | 174 | 3 | 18417546 | |
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 10388558 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 11023856 | ||
| Pubmed | 5.83e-07 | 14 | 174 | 4 | 27184118 | ||
| Pubmed | 1.02e-06 | 66 | 174 | 6 | 19898482 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.22e-06 | 5 | 174 | 3 | 30737693 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 1.75e-06 | 18 | 174 | 4 | 25753484 | |
| Pubmed | 1.92e-06 | 41 | 174 | 5 | 23676014 | ||
| Pubmed | Autoregulation of the 26S proteasome by in situ ubiquitination. | 2.21e-06 | 19 | 174 | 4 | 24743594 | |
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 2.43e-06 | 6 | 174 | 3 | 17559643 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 MYH4 THNSL1 MYO1C TTC28 PSMB5 FBXO11 KEAP1 HUWE1 KLHL20 ATG4B CLPB OTUD6B ASXL2 TAF5L HERC2 CDC27 USP48 | 3.31e-06 | 1005 | 174 | 18 | 19615732 |
| Pubmed | 4.13e-06 | 22 | 174 | 4 | 24301466 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 4.24e-06 | 7 | 174 | 3 | 29758057 | |
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 25740311 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 SIN3B MYH4 COL8A1 REM1 UBR4 ESX1 UNC93A HUWE1 DOCK5 OR2K2 PARP4 FBXO10 ADAMTS9 LRP2 | 4.96e-06 | 736 | 174 | 15 | 29676528 |
| Pubmed | 6.77e-06 | 8 | 174 | 3 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 6.77e-06 | 8 | 174 | 3 | 14667415 | |
| Pubmed | 6.77e-06 | 8 | 174 | 3 | 26993635 | ||
| Pubmed | 6.77e-06 | 8 | 174 | 3 | 3864153 | ||
| Pubmed | 6.77e-06 | 8 | 174 | 3 | 36163178 | ||
| Pubmed | USP34 TTC28 ADAM23 ADAM9 UBR4 FBXW4 FBXO11 CACHD1 HUWE1 ARMCX4 BRWD3 PTPN13 CLPB ADAMTS9 RCBTB1 GLS LRP2 ASTN2 HERC2 PREX1 | 7.50e-06 | 1285 | 174 | 20 | 35914814 | |
| Pubmed | SIN3B DELE1 PARP4 ADAMTS9 GLCE GLS NUP210 ASTN2 ARHGAP28 PLCH1 KLHDC10 PREX1 | 7.91e-06 | 493 | 174 | 12 | 15368895 | |
| Pubmed | USP34 AKT3 TMEM248 B3GNT5 UGGT1 LMTK2 FBXO11 HUWE1 MIER1 SLC6A2 CDK5RAP3 PTPN13 NFE2L1 LRP2 ASXL2 KLHDC10 CDC27 AGRN | 9.31e-06 | 1084 | 174 | 18 | 11544199 | |
| Pubmed | 1.01e-05 | 9 | 174 | 3 | 31960486 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 FKBP10 TMEM248 ADAM9 UGGT1 ERMP1 CACHD1 HMOX1 PLXNB2 TMED3 PCYOX1L CELSR1 GLCE NUP210 EBP UBIAD1 USP48 AGRN ADGRA3 | 1.02e-05 | 1201 | 174 | 19 | 35696571 |
| Pubmed | 1.13e-05 | 28 | 174 | 4 | 35474067 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.44e-05 | 10 | 174 | 3 | 15345741 | |
| Pubmed | 1.44e-05 | 10 | 174 | 3 | 19506036 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.44e-05 | 10 | 174 | 3 | 8950513 | |
| Pubmed | 1.78e-05 | 64 | 174 | 5 | 22261194 | ||
| Pubmed | 1.97e-05 | 11 | 174 | 3 | 18310078 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.97e-05 | 11 | 174 | 3 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.97e-05 | 11 | 174 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.97e-05 | 11 | 174 | 3 | 29168801 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.21e-05 | 33 | 174 | 4 | 32094117 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.49e-05 | 2 | 174 | 2 | 9585413 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 10222050 | ||
| Pubmed | Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1). | 2.49e-05 | 2 | 174 | 2 | 12218062 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 33400134 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16575183 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.49e-05 | 2 | 174 | 2 | 9382868 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 11150240 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17263731 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 2.49e-05 | 2 | 174 | 2 | 22337492 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19300908 | ||
| Pubmed | Antioxidant effect of a nitrated cyclic nucleotide functioning as an endogenous electrophile. | 2.49e-05 | 2 | 174 | 2 | 21506927 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 28487965 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15319348 | ||
| Pubmed | Regulation of the TAK1 signaling pathway by protein phosphatase 2C. | 2.49e-05 | 2 | 174 | 2 | 11104763 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 27482120 | ||
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 2.49e-05 | 2 | 174 | 2 | 11551968 | |
| Pubmed | Sequence and expression patterns of a human EMAP-related protein-2 (HuEMAP-2). | 2.49e-05 | 2 | 174 | 2 | 10521658 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 22876132 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16847254 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 34000957 | ||
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 2.49e-05 | 2 | 174 | 2 | 8518795 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 22768135 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 2.49e-05 | 2 | 174 | 2 | 7545970 | |
| Pubmed | PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer. | 2.49e-05 | 2 | 174 | 2 | 38039548 | |
| Pubmed | Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. | 2.49e-05 | 2 | 174 | 2 | 38679985 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 21679149 | ||
| Pubmed | Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent kinase isoforms. | 2.49e-05 | 2 | 174 | 2 | 12590200 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 21102503 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23295186 | ||
| Pubmed | Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer. | 2.49e-05 | 2 | 174 | 2 | 33388371 | |
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 2.49e-05 | 2 | 174 | 2 | 11744674 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH4 MYH8 MYO1C MYO1D UGGT1 UBR4 PSMB5 PSMB8 HUWE1 NUP210 KLHDC10 | 2.51e-05 | 647 | 174 | 13 | 26618866 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH2 MYH4 HTR1E MYO1C MYO1D SGK1 UGGT1 UBR4 PSMB5 EML2 PKD1L3 EML3 PPM1B CRB1 CDK5RAP3 ATG4B ASXL2 HERC2 PREX1 | 2.57e-05 | 1284 | 174 | 19 | 17353931 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.62e-05 | 12 | 174 | 3 | 20308471 | |
| Pubmed | Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. | 2.62e-05 | 12 | 174 | 3 | 24687281 | |
| Pubmed | 2.62e-05 | 12 | 174 | 3 | 18161889 | ||
| Pubmed | 3.39e-05 | 13 | 174 | 3 | 8948582 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 4.03e-05 | 183 | 174 | 7 | 31932471 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 4.30e-05 | 14 | 174 | 3 | 27626314 | |
| Pubmed | 4.30e-05 | 14 | 174 | 3 | 33742095 | ||
| Pubmed | 4.30e-05 | 14 | 174 | 3 | 24938781 | ||
| Pubmed | 4.34e-05 | 39 | 174 | 4 | 38690566 | ||
| Pubmed | DDI2 protease controls embryonic development and inflammation via TCF11/NRF1. | 4.81e-05 | 40 | 174 | 4 | 39328932 | |
| Pubmed | 4.91e-05 | 257 | 174 | 8 | 16335952 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 5.36e-05 | 15 | 174 | 3 | 24852826 | |
| Pubmed | 6.57e-05 | 16 | 174 | 3 | 16494860 | ||
| Interaction | UBC interactions | USP34 KLHL28 UBR4 LMTK2 KEAP1 HUWE1 PPM1B CLPB EBP LRP2 HERC2 KLHDC10 CDC27 MAP3K7 USP48 | 6.00e-06 | 446 | 170 | 15 | int:UBC |
| Interaction | LINC02694 interactions | 1.16e-05 | 6 | 170 | 3 | int:LINC02694 | |
| GeneFamily | UDP glucuronosyltransferases | 2.24e-06 | 32 | 122 | 5 | 363 | |
| GeneFamily | Myosin heavy chains | 2.54e-06 | 15 | 122 | 4 | 1098 | |
| GeneFamily | Kelch like|BTB domain containing | 8.97e-06 | 42 | 122 | 5 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.46e-05 | 134 | 122 | 7 | 861 | |
| GeneFamily | Collagens | 2.59e-04 | 46 | 122 | 4 | 490 | |
| GeneFamily | Fibronectin type III domain containing | 7.59e-04 | 160 | 122 | 6 | 555 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 9.28e-04 | 7 | 122 | 2 | 785 | |
| GeneFamily | Myosins, class I | 1.23e-03 | 8 | 122 | 2 | 1097 | |
| GeneFamily | WD repeat domain containing | 2.02e-03 | 262 | 122 | 7 | 362 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.69e-07 | 20 | 173 | 5 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 2.21e-07 | 21 | 173 | 5 | MM1102 | |
| Coexpression | PILON_KLF1_TARGETS_UP | FKBP10 HMOX1 HUWE1 MIER1 ITIH3 KLHL20 ACOX2 EBP UGT2B4 UGT2B7 PCSK7 ASXL2 UGT2B28 UGT2B11 CDH5 AGRN | 6.65e-07 | 541 | 173 | 16 | MM1061 |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 2.63e-05 | 53 | 173 | 5 | MM1203 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 1.52e-05 | 178 | 172 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-10 | 160 | 174 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-10 | 160 | 174 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-09 | 189 | 174 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA13 FAT3 ERMP1 PARP4 CFAP54 UGT2B7 DNAI4 ASTN2 ADGRA3 CACNA2D3 | 4.43e-09 | 191 | 174 | 10 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-08 | 164 | 174 | 9 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-08 | 184 | 174 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-08 | 184 | 174 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-08 | 184 | 174 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D ABCA13 PARP4 CELSR1 CFAP54 ADAMTS9 UGT2B7 ASTN2 CACNA2D3 | 5.78e-08 | 188 | 174 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.57e-08 | 194 | 174 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-08 | 194 | 174 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-07 | 175 | 174 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-07 | 184 | 174 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.50e-07 | 190 | 174 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.84e-07 | 191 | 174 | 8 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.19e-07 | 192 | 174 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-07 | 193 | 174 | 8 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.56e-07 | 193 | 174 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.56e-07 | 193 | 174 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.94e-07 | 194 | 174 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.94e-07 | 194 | 174 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-06 | 195 | 174 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.12e-06 | 197 | 174 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-06 | 198 | 174 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.20e-06 | 199 | 174 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-06 | 200 | 174 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-06 | 200 | 174 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-06 | 200 | 174 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 145 | 174 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-06 | 151 | 174 | 7 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.31e-06 | 167 | 174 | 7 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 168 | 174 | 7 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 168 | 174 | 7 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 172 | 174 | 7 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 172 | 174 | 7 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 175 | 174 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 177 | 174 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.50e-06 | 67 | 174 | 5 | e53dfc288c943656a0b064afe593ea2101d75437 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.50e-06 | 67 | 174 | 5 | 1841cee311a4b1b802c9e872793435afb730592f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-06 | 181 | 174 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-06 | 181 | 174 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 181 | 174 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-06 | 182 | 174 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-06 | 182 | 174 | 7 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 183 | 174 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.05e-06 | 187 | 174 | 7 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.37e-06 | 188 | 174 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-06 | 188 | 174 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-06 | 189 | 174 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 191 | 174 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 191 | 174 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.07e-05 | 192 | 174 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 192 | 174 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.07e-05 | 192 | 174 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 192 | 174 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-05 | 127 | 174 | 6 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.11e-05 | 193 | 174 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-05 | 194 | 174 | 7 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 194 | 174 | 7 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 195 | 174 | 7 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 195 | 174 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 195 | 174 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.19e-05 | 195 | 174 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-05 | 196 | 174 | 7 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-05 | 196 | 174 | 7 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-05 | 196 | 174 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 130 | 174 | 6 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 130 | 174 | 6 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 130 | 174 | 6 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 197 | 174 | 7 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.27e-05 | 197 | 174 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 197 | 174 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 174 | 7 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 199 | 174 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.35e-05 | 199 | 174 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 199 | 174 | 7 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 199 | 174 | 7 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 199 | 174 | 7 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 174 | 7 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 174 | 7 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.40e-05 | 200 | 174 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 174 | 7 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 79 | 174 | 5 | eddad041c0bc6952d9c68a36bdd78f6d661f0e58 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 79 | 174 | 5 | 4c9c3051cb8a9c39c6df20e3fe37242db4b44280 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocye.Tnr.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 134 | 174 | 6 | bc550d3b44f1e1e1c18971c110e816bcffd79d14 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 134 | 174 | 6 | 90a34ae53a602a92f6f998e7cf061d8f4f0da527 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 143 | 174 | 6 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 43 | 174 | 4 | 7027858b46c0aabec290ed3888201a1b39e10552 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 43 | 174 | 4 | 0282410243ba125ec13fd6af737ddf952e493280 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-05 | 162 | 174 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.88e-05 | 166 | 174 | 6 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.05e-05 | 167 | 174 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.05e-05 | 167 | 174 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.05e-05 | 167 | 174 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 169 | 174 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 170 | 174 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 174 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| Drug | C1 11-32 | 1.89e-07 | 18 | 173 | 5 | CID000443077 | |
| Drug | C11131 | 1.89e-07 | 18 | 173 | 5 | CID000443076 | |
| Drug | ethoxyquin | 2.60e-07 | 116 | 173 | 9 | CID000003293 | |
| Drug | benzphetamine | UGT1A6 HMOX1 SLC6A2 AOC3 UGT2B4 UGT2B7 UGT2B28 UGT2B11 SLC14A2 | 3.24e-07 | 119 | 173 | 9 | CID000002341 |
| Drug | l-borneol | 3.37e-07 | 37 | 173 | 6 | CID000010049 | |
| Drug | estriol-16-glucuronide | 4.41e-07 | 21 | 173 | 5 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 7.20e-07 | 23 | 173 | 5 | CID000066651 | |
| Drug | MS-222 | 9.80e-07 | 44 | 173 | 6 | CID000011400 | |
| Drug | SN-38 | MYH2 MYH4 UGT1A6 HMOX1 CHEK2 UGT2B4 UGT2B7 PCSK7 UGT2B28 UGT2B11 | 1.52e-06 | 184 | 173 | 10 | CID000104842 |
| Drug | salicylamide | 1.66e-06 | 48 | 173 | 6 | CID000005147 | |
| Drug | 16-epiestriol | 1.99e-06 | 77 | 173 | 7 | CID000003269 | |
| Drug | formycin triphosphate | 2.39e-06 | 51 | 173 | 6 | CID000122274 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.45e-06 | 29 | 173 | 5 | CID000125641 | |
| Drug | AC1NQGK1 | 2.69e-06 | 52 | 173 | 6 | CID005195977 | |
| Drug | 7-ethoxycoumarin | 4.20e-06 | 86 | 173 | 7 | CID000035703 | |
| Drug | AC1Q6OQG | 4.77e-06 | 33 | 173 | 5 | CID000009686 | |
| Drug | BP-3,6-quinol | 4.77e-06 | 33 | 173 | 5 | CID000119292 | |
| Drug | purealin | 5.15e-06 | 58 | 173 | 6 | CID006419303 | |
| Drug | urochloralic acid | 5.69e-06 | 59 | 173 | 6 | CID003036914 | |
| Drug | AC1NOWCJ | 6.45e-06 | 35 | 173 | 5 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 6.45e-06 | 35 | 173 | 5 | CID010436171 | |
| Drug | estrone-3-glucuronide | 6.45e-06 | 35 | 173 | 5 | CID000115255 | |
| Drug | 3-OHBaP | 8.37e-06 | 63 | 173 | 6 | CID000025890 | |
| Drug | oltipraz | 1.03e-05 | 137 | 173 | 8 | CID000047318 | |
| Drug | T4-G | 1.14e-05 | 19 | 173 | 4 | CID000152424 | |
| Drug | S-(-)-Etomoxir | 1.14e-05 | 100 | 173 | 7 | CID000060765 | |
| Drug | harmol | 1.27e-05 | 40 | 173 | 5 | CID000068094 | |
| Drug | testosterone glucuronide | 1.44e-05 | 41 | 173 | 5 | CID000108192 | |
| Drug | chondroitin sulfate | MAG COL6A3 COL8A1 COL17A1 UGT1A6 FREM3 ADAMTS9 GLCE UGT2B4 UGT2B7 UGT2B28 UGT2B11 AGRN | 1.74e-05 | 413 | 173 | 13 | CID000024766 |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.76e-05 | 193 | 173 | 9 | 4322_UP | |
| Drug | androsterone glucuronide | 1.82e-05 | 43 | 173 | 5 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.82e-05 | 43 | 173 | 5 | CID000009191 | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.99e-05 | 196 | 173 | 9 | 4723_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HG-U133A | 2.07e-05 | 197 | 173 | 9 | 1410_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 2.15e-05 | 198 | 173 | 9 | 1997_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.24e-05 | 199 | 173 | 9 | 6349_UP | |
| Drug | phenolate | OPN4 UGT1A6 IFI44 HMOX1 CRYM UGT2B4 UGT2B7 UGT2B28 C8B UGT2B11 | 2.59e-05 | 254 | 173 | 10 | CID000000996 |
| Drug | benzyloxyresorufin | 2.88e-05 | 78 | 173 | 6 | CID000114982 | |
| Drug | 8-azaguanine | 2.88e-05 | 78 | 173 | 6 | CID000008646 | |
| Drug | AC1Q7AUJ | 3.18e-05 | 117 | 173 | 7 | CID000003303 | |
| Drug | Hymecromone | 3.60e-05 | 25 | 173 | 4 | ctd:D006923 | |
| Drug | licochalcone A | 4.93e-05 | 27 | 173 | 4 | ctd:C070840 | |
| Drug | menthol | 5.36e-05 | 87 | 173 | 6 | CID000001254 | |
| Drug | pentoxyresorufin | 5.36e-05 | 87 | 173 | 6 | CID000107683 | |
| Drug | L-idaro-1,4-lactone | 5.72e-05 | 28 | 173 | 4 | CID000078997 | |
| Drug | monascusic acid A | 5.74e-05 | 2 | 173 | 2 | ctd:C548427 | |
| Drug | benzenearsonic acid | 5.74e-05 | 2 | 173 | 2 | ctd:C020979 | |
| Drug | 2-hydroxyestriol | 5.74e-05 | 2 | 173 | 2 | ctd:C008012 | |
| Drug | AC1L1FK5 | 5.94e-05 | 129 | 173 | 7 | CID000003272 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 6.59e-05 | 29 | 173 | 4 | CID005375667 | |
| Drug | silibinin | COL6A3 COL8A1 COL17A1 UGT1A6 HMOX1 CHEK2 UGT2B4 UGT2B7 UGT2B28 UGT2B11 | 6.83e-05 | 285 | 173 | 10 | CID000005213 |
| Drug | p-nitroanisole | 7.33e-05 | 92 | 173 | 6 | CID000007485 | |
| Drug | phenolphthalein | 7.91e-05 | 58 | 173 | 5 | CID000004764 | |
| Drug | 4-hydroxybiphenyl | 8.59e-05 | 59 | 173 | 5 | CID000007103 | |
| Drug | 4-hydroxyestrone | 8.59e-05 | 59 | 173 | 5 | CID000018418 | |
| Drug | acetaminophen glucuronide | 8.59e-05 | 59 | 173 | 5 | CID000083944 | |
| Drug | SN-38G | 8.59e-05 | 59 | 173 | 5 | CID000443154 | |
| Drug | ethoxyresorufin | 8.77e-05 | 95 | 173 | 6 | CID000003294 | |
| Drug | DCNB | 8.77e-05 | 95 | 173 | 6 | CID000007443 | |
| Drug | UDP-alpha-d-xylopyranose | 9.31e-05 | 60 | 173 | 5 | CID000001165 | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 9.50e-05 | 187 | 173 | 8 | 6872_DN | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 189 | 173 | 8 | 6003_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.10e-04 | 191 | 173 | 8 | 6987_DN | |
| Drug | butylated hydroxytoluene | 1.14e-04 | 143 | 173 | 7 | CID000031404 | |
| Drug | creatine | 1.18e-04 | 193 | 173 | 8 | CID000000586 | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.23e-04 | 194 | 173 | 8 | 2998_UP | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.23e-04 | 194 | 173 | 8 | 1267_UP | |
| Drug | 2 E1 | 1.24e-04 | 145 | 173 | 7 | CID006102788 | |
| Drug | 2-butyl-6-methoxyphenol | 1.36e-04 | 197 | 173 | 8 | CID011954184 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.36e-04 | 197 | 173 | 8 | 3566_DN | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.41e-04 | 198 | 173 | 8 | 4096_UP | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 1.41e-04 | 198 | 173 | 8 | 6421_DN | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.46e-04 | 199 | 173 | 8 | 3839_UP | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; HL60; HG-U133A | 1.46e-04 | 199 | 173 | 8 | 1965_DN | |
| Drug | propranolol glucuronide | 1.48e-04 | 14 | 173 | 3 | CID000119515 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HG-U133A | 1.51e-04 | 200 | 173 | 8 | 1955_DN | |
| Drug | glucoraphanin | 1.57e-04 | 36 | 173 | 4 | CID000656556 | |
| Drug | Meldola | 1.69e-04 | 68 | 173 | 5 | CID000081507 | |
| Drug | histidyl-proline diketopiperazine | 1.71e-04 | 3 | 173 | 2 | ctd:C015924 | |
| Drug | 5 alpha-dihydroaldosterone | 1.71e-04 | 3 | 173 | 2 | CID003036614 | |
| Drug | 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone | 1.71e-04 | 3 | 173 | 2 | ctd:C093027 | |
| Drug | methoxyresorufin | 1.81e-04 | 69 | 173 | 5 | CID000119220 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 155 | 173 | 7 | 6817_DN | |
| Drug | 2-naphthylamine | 1.97e-04 | 110 | 173 | 6 | CID000007057 | |
| Drug | BAPN | 2.08e-04 | 71 | 173 | 5 | CID000001647 | |
| Drug | eugenol | 2.37e-04 | 73 | 173 | 5 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 2.37e-04 | 73 | 173 | 5 | CID000008259 | |
| Drug | AC1LCF1F | 2.37e-04 | 161 | 173 | 7 | CID000627275 | |
| Drug | carvedilol | 2.37e-04 | 161 | 173 | 7 | CID000002585 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.73e-07 | 12 | 167 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.73e-07 | 12 | 167 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.80e-07 | 13 | 167 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.29e-06 | 15 | 167 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | testis-expressed sequence 29 protein measurement | 9.77e-06 | 8 | 167 | 3 | EFO_0802125 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.46e-05 | 9 | 167 | 3 | EFO_0600040 | |
| Disease | breast neoplasm | 3.18e-05 | 2 | 167 | 2 | EFO_0003869 | |
| Disease | X-19141 measurement | 4.88e-05 | 13 | 167 | 3 | EFO_0800799 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.27e-05 | 71 | 167 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | vitamin D deficiency | 5.65e-05 | 37 | 167 | 4 | EFO_0003762 | |
| Disease | white matter microstructure measurement | 8.15e-05 | 390 | 167 | 10 | EFO_0005674 | |
| Disease | phosphatidylcholine 36:4 measurement | 1.36e-04 | 18 | 167 | 3 | EFO_0010382 | |
| Disease | myopathy (implicated_via_orthology) | 1.59e-04 | 48 | 167 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | anti-Mullerian hormone measurement | 1.89e-04 | 20 | 167 | 3 | EFO_0004769 | |
| Disease | Exudative retinopathy | 1.90e-04 | 4 | 167 | 2 | C0154832 | |
| Disease | arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 measurement | 1.90e-04 | 4 | 167 | 2 | EFO_0803306 | |
| Disease | X-24947 measurement | 2.53e-04 | 22 | 167 | 3 | EFO_0800910 | |
| Disease | AP-4 complex subunit mu-1 measurement | 3.15e-04 | 5 | 167 | 2 | EFO_0801385 | |
| Disease | Congenital absence of kidneys syndrome | 3.15e-04 | 5 | 167 | 2 | C1609433 | |
| Disease | disease progression measurement | 4.02e-04 | 61 | 167 | 4 | EFO_0008336 | |
| Disease | cyclin-dependent kinase 8:cyclin-c complex measurement | 4.71e-04 | 6 | 167 | 2 | EFO_0020297 | |
| Disease | n-acetylserotonin O-methyltransferase-like protein measurement | 4.71e-04 | 6 | 167 | 2 | EFO_0801818 | |
| Disease | ubiquitin-like protein ISG15 measurement | 4.71e-04 | 6 | 167 | 2 | EFO_0021875 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 4.71e-04 | 27 | 167 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Myocardial Ischemia | 5.15e-04 | 176 | 167 | 6 | C0151744 | |
| Disease | hypertension (is_implicated_in) | 6.41e-04 | 121 | 167 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | osteocalcin measurement | 6.56e-04 | 7 | 167 | 2 | EFO_0010232 | |
| Disease | anorexia nervosa | 6.79e-04 | 70 | 167 | 4 | MONDO_0005351 | |
| Disease | Unilateral agenesis of kidney | 8.72e-04 | 8 | 167 | 2 | C0266294 | |
| Disease | Parkinsonism (biomarker_via_orthology) | 9.37e-04 | 34 | 167 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | reticulocyte measurement | USP34 KLHL10 MYO1D PSMB5 PLXNB2 TFR2 DOCK5 OR2K2 GLS CHEK2 UQCC1 ASXL2 RAB1A USP48 PREX1 | 9.91e-04 | 1053 | 167 | 15 | EFO_0010700 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.11e-03 | 36 | 167 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | complement component C8 measurement | 1.12e-03 | 9 | 167 | 2 | EFO_0008094 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 1.12e-03 | 9 | 167 | 2 | EFO_0021876 | |
| Disease | heterogeneous nuclear ribonucleoprotein q measurement | 1.12e-03 | 9 | 167 | 2 | EFO_0020443 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.12e-03 | 80 | 167 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 TRIML1 UBR4 XDH DDO KEAP1 HMOX1 SGK3 CHEK2 ASTN2 UQCC1 HERC2 KLHDC10 CDC27 CDH5 | 1.21e-03 | 1074 | 167 | 15 | C0006142 |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.69e-03 | 11 | 167 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | vital capacity | USP34 MYH2 COL6A3 COL8A1 MYO1C IFI44 PKD1L3 EML3 RYR2 CDK5RAP3 LRP2 ASTN2 UQCC1 SLC14A2 KDM4B CACNA2D3 | 1.81e-03 | 1236 | 167 | 16 | EFO_0004312 |
| Disease | pulse pressure measurement | USP34 COL6A3 COL8A1 MYO1C TTC28 FAT3 DELE1 PKD1L3 PLXNB2 ITIH3 SLC5A11 OTUD6B UGT2B7 UQCC1 EML1 SLC14A2 KDM4B | 2.41e-03 | 1392 | 167 | 17 | EFO_0005763 |
| Disease | Ischemic stroke | 2.56e-03 | 324 | 167 | 7 | HP_0002140 | |
| Disease | Major Depressive Disorder | 2.68e-03 | 243 | 167 | 6 | C1269683 | |
| Disease | vitamin D measurement, COVID-19 | 2.71e-03 | 49 | 167 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.77e-03 | 14 | 167 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | FEV change measurement, response to corticosteroid | 2.77e-03 | 14 | 167 | 2 | EFO_0005921, GO_0031960 | |
| Disease | urinary metabolite measurement | 2.79e-03 | 245 | 167 | 6 | EFO_0005116 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.04e-03 | 105 | 167 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | AKT3 FAT3 EML2 PLXNB2 KLHL20 CELSR1 PAPPA UQCC1 TOMM40 EML1 PLCH1 MAP3K7 AGBL1 KDM4B | 3.14e-03 | 1069 | 167 | 14 | EFO_0004346 |
| Disease | Hepatitis | 3.19e-03 | 15 | 167 | 2 | C0019158 | |
| Disease | generalised epilepsy | 3.21e-03 | 52 | 167 | 3 | EFO_0005917 | |
| Disease | interleukin 1 receptor antagonist measurement | 3.39e-03 | 53 | 167 | 3 | EFO_0004754 | |
| Disease | Early Pregnancy Loss | 3.47e-03 | 109 | 167 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 3.47e-03 | 109 | 167 | 4 | C0000786 | |
| Disease | Miscarriage | 3.47e-03 | 109 | 167 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 3.47e-03 | 109 | 167 | 4 | C0000822 | |
| Disease | Alzheimer disease, age at onset | 3.50e-03 | 343 | 167 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | estradiol measurement | 3.59e-03 | 110 | 167 | 4 | EFO_0004697 | |
| Disease | optic cup area measurement | 3.96e-03 | 56 | 167 | 3 | EFO_0006940 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.08e-03 | 447 | 167 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.10e-03 | 17 | 167 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | copine-1 measurement | 4.10e-03 | 17 | 167 | 2 | EFO_0008102 | |
| Disease | cortical surface area measurement | USP34 AKT3 ATP8A2 FAT3 EML2 CACHD1 PLXNB2 CELSR1 ADAMTS9 GLS PAPPA ASTN2 ARHGAP28 EML1 MAP3K7 AGBL1 | 4.15e-03 | 1345 | 167 | 16 | EFO_0010736 |
| Disease | cortical thickness | AKT3 FAT3 EML2 CELSR1 ADAMTS9 GLS ASTN2 UQCC1 EML1 PLCH1 MAP3K7 AGBL1 KDM4B CACNA2D3 | 4.48e-03 | 1113 | 167 | 14 | EFO_0004840 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.59e-03 | 18 | 167 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 5.11e-03 | 19 | 167 | 2 | EFO_0007709 | |
| Disease | Acute Myeloid Leukemia, M1 | 5.64e-03 | 125 | 167 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 5.64e-03 | 125 | 167 | 4 | C1879321 | |
| Disease | taurocholate measurement | 5.66e-03 | 20 | 167 | 2 | EFO_0010538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASHVVSYLRTSGYGV | 1061 | Q9UMD9 | |
| GYTHSDIGYRSLAVG | 6 | Q8N693 | |
| YAQTELGHGTYLQGL | 151 | Q99424 | |
| GYSEDIFHLAATLYV | 576 | Q96N23 | |
| GLLSSDYVEIHYENG | 171 | O75077 | |
| LGVQDFGTAYAHYLL | 36 | Q6P2P2 | |
| SLSGDAYLALSHGYA | 6 | Q8NDY6 | |
| AYLALSHGYAAAAAG | 11 | Q8NDY6 | |
| IATYRLAGGAHVYST | 521 | Q8IWK6 | |
| VYHLDEGVYGIFNSV | 316 | Q96A70 | |
| TSNHVSYNGLYGVAV | 661 | Q9UK96 | |
| QHDHVIYTIYSTLGA | 176 | P28566 | |
| YVALAIVDGHLQLSY | 1941 | O00468 | |
| YVASQSVLSVYAHGR | 176 | Q8TC94 | |
| YLDVGGAGYVVTISH | 776 | Q5VU97 | |
| NSVGNSIYHLASYLA | 1591 | Q86UQ4 | |
| GSTDHVIRIYYLGSE | 336 | Q6RI45 | |
| LYDTGSGTIYDLRHF | 551 | O94923 | |
| YSILSGNVAGQFYLH | 496 | Q9NYQ6 | |
| VQVHEYLGLAGDTLY | 116 | Q9H8S5 | |
| YIAYIEDHSGNGTFV | 156 | O96017 | |
| DTLHIYGYEGSESIA | 726 | P33151 | |
| VGLSVDFAVHYGVAY | 1046 | Q96F81 | |
| GIDLAFIENGYIYHT | 341 | Q7Z2K6 | |
| DYSYSHEVVRNVGGI | 2071 | Q5H9R4 | |
| GSHYIAEALYGSELT | 901 | O75129 | |
| AGHYLLNISTYGRGS | 1121 | Q76L83 | |
| SGHATDYLFVGNIVY | 991 | Q9NTI2 | |
| NSAHYFIGYVGEELI | 261 | Q9Y4P1 | |
| YGAEIVSALDYLHSG | 251 | Q9Y243 | |
| YKNHYRQSTAVAGGA | 691 | Q96MI9 | |
| DLYSHYFGGLAETVL | 446 | Q16853 | |
| ILGAGVQAYSHYEIF | 141 | Q14894 | |
| SQYALQYAGDGSVLL | 736 | Q14494 | |
| IGVHGYVLVYSVTSL | 76 | Q8TAI7 | |
| GYAHTLALTDEGLLY | 241 | Q8NDN9 | |
| YAHTLVLTDEGQVYA | 266 | O95199 | |
| ITSSYYRGAHGIIVV | 76 | P62820 | |
| AVNDLGTEYVHRYVG | 296 | O94925 | |
| AIAYATHRDSYSGGV | 231 | P28062 | |
| GVTNGYNHAILAYAF | 916 | Q6IE37 | |
| GSVTVYYEVAGHLRT | 1531 | Q8TEM1 | |
| VQRQGVSYSVHAYTG | 61 | Q8IVT2 | |
| VGVSIYTSHYANRDG | 111 | P54849 | |
| LGGYNQYTFSEHSVL | 121 | P20916 | |
| IFSGGLQTSQIHYSY | 1341 | O95714 | |
| ISYYNHIDSLFGLDV | 336 | Q5W064 | |
| VVGIHGDSPYYFLTS | 146 | Q96BI3 | |
| ANVYLASDGEYSLHG | 361 | O95671 | |
| ALDHAGYSGLYEAIE | 76 | O95786 | |
| LHQEGIYAGVYSATF | 3961 | Q5CZC0 | |
| SLIHYAGTVDYNITG | 581 | P13535 | |
| GYANSIYTVTIGAVD | 341 | Q16549 | |
| YQAHGYAFSGVEELL | 161 | Q8NBM8 | |
| EASGVVYLGAVNALY | 41 | O15031 | |
| VFGGTTGYIYSTDLH | 221 | Q6PID8 | |
| ALIHYAGVVDYNITG | 581 | Q9UKX2 | |
| LSHLLSQYYGAGVAR | 296 | Q96PD5 | |
| AVGISYISVYDHQGI | 126 | Q96E22 | |
| NGTDIIYNYHGIVSL | 1941 | Q5H8C1 | |
| YAEGGSLYNVLHGAE | 106 | O43318 | |
| GISADYIGGSHYVIQ | 16 | P25208 | |
| YVAYIESQGAHRAGL | 31 | O94953 | |
| GVYAVATLVYHALGR | 126 | Q6ZV70 | |
| TLSNYYVDSLIGHEG | 16 | P28356 | |
| RGHLDEGLSYTSIFY | 491 | Q8IWU2 | |
| SLIHYAGTVDYNIAG | 581 | P12882 | |
| HSIYVSEGYNAAAIL | 416 | Q8N159 | |
| AAVHAFGLTLYGQYI | 2591 | P98164 | |
| QEYLEAVTQGHGAYL | 691 | Q9UKK3 | |
| AAAVIVHLVTDGTYY | 1096 | Q13219 | |
| YSDSELGHVGSYLQG | 301 | Q6PEW0 | |
| YHLASYDAGGEALVS | 391 | Q7Z6Z7 | |
| GGHTYNISVYAVNSA | 1756 | Q9UMZ3 | |
| VEHFIRDGSGLTYIY | 211 | Q99489 | |
| VTLTGGYLHIYESQL | 121 | Q9Y6W8 | |
| ALVAFAGYAHVLTPY | 316 | Q9UHM6 | |
| AYGLGEHYNSVTRLV | 271 | Q8N6M0 | |
| DYTAGAAYVISGDVA | 251 | Q9BYG0 | |
| AGTFNTVHYGYNTVV | 756 | Q9P2N4 | |
| FVRYHYNGTLLDGTS | 176 | Q96AY3 | |
| GANYGHVYAVFETAT | 296 | P51553 | |
| LTVIYSEDHIIGAYA | 51 | Q8TCB0 | |
| SGIGVIAYGEHVYAV | 471 | Q6JEL2 | |
| YAVGGYDSSSHLATV | 486 | Q6TDP4 | |
| LLYAVGGHDGSSYLN | 366 | Q9Y2M5 | |
| AAVIDNYLYVVGGHS | 521 | Q9NXS3 | |
| RGQSIFSTIHTYGLY | 211 | Q9H7D0 | |
| HGYAFAITNNGYILT | 521 | Q8IZS8 | |
| GLGRHTEYDVTILAY | 706 | Q9P218 | |
| VGLYITDHAQGIYED | 411 | Q86XK2 | |
| SEEIAQLLSGSYIHY | 51 | Q96JB5 | |
| IGTVGIASYDYHQGS | 161 | Q6V1X1 | |
| GLNTGSALSYVYANH | 716 | P12111 | |
| IDQYGTHYLQSGSLG | 296 | P10643 | |
| THYLQSGSLGGEYRV | 301 | P10643 | |
| YGNNGVSSTAKLYVH | 241 | Q8TDW7 | |
| YRGYVEGVHNSSIAL | 116 | Q13443 | |
| EQAAGLYAGQYVHSS | 721 | P27658 | |
| DGNHLLATGSSYYGV | 346 | P57775 | |
| LLAVGYHNGTIAIYN | 551 | Q5VTH9 | |
| IYVLGGYDGHTFLDS | 566 | Q14145 | |
| AHAYTRYLGDLSGGQ | 131 | P09601 | |
| ADVLVDGYNVHYGAR | 606 | Q9H078 | |
| LAIGSHDNCIYIYGV | 641 | O00423 | |
| DGAYLAVGSHDNLVY | 471 | O95834 | |
| DGLYLAIGSHDNVIY | 691 | Q32P44 | |
| AIGSHDNVIYIYSVS | 696 | Q32P44 | |
| YGEQTLHYIATNGES | 251 | Q9BY44 | |
| EIGGIYLSYFENVHG | 1101 | P82279 | |
| VGQIYGDVLYFLTEH | 156 | Q15125 | |
| GHYNINFISSLGVSY | 56 | Q96IW7 | |
| EVAAYNSAGLGVYSS | 766 | Q58EX2 | |
| VSSERYLHLSYGNGS | 186 | Q92736 | |
| YLHLSYGNGSLHVDA | 191 | Q92736 | |
| YAAEIASALGYLHSI | 266 | Q96BR1 | |
| AYAYTLLGHEFVLTE | 601 | P30260 | |
| VGVSLTYYAVSGHLV | 2566 | Q8TDX9 | |
| TYYAVSGHLVTLAGD | 2571 | Q8TDX9 | |
| GTHYITEAVLGGIYE | 341 | P07358 | |
| VLYYQLAASQGHSLA | 301 | Q14154 | |
| IHELLSLYGYGSTVR | 66 | Q8N108 | |
| SLCGGHDSLYQVVYI | 1896 | Q12923 | |
| LQGGSAYVIVYSIAD | 151 | O75628 | |
| GAHLTVVILYYGAAL | 241 | Q8NGT1 | |
| GVNTLTDHYFYVTIG | 1406 | P0C091 | |
| LYHGGGVYIIDVSQS | 331 | Q9BRS2 | |
| LGSFTNTVLYQGHAY | 371 | O75529 | |
| SLALTGAVVAHAYYL | 11 | Q86TM6 | |
| GASNGINAYLHIDFY | 286 | P23975 | |
| EYLYRVIASHEGGSV | 1926 | O75445 | |
| FGGYSRNVTHLYSTI | 126 | Q9NWD8 | |
| TYQHFYDGSEIVVAG | 491 | Q06033 | |
| GSRVLYFGDHIYSDL | 381 | Q86UY8 | |
| IASALGYLHSLNIVY | 206 | O00141 | |
| HGIGTYYITAVLSER | 601 | Q7Z443 | |
| LEHGVVYEYVSTAGV | 851 | Q8TCU6 | |
| HLARYVEQYVGTEGA | 986 | O75182 | |
| YTVAGGLAAVIYTDA | 191 | Q8WWX8 | |
| SLVHYAGTVDYNIAG | 581 | Q9Y623 | |
| FAVYDGHAGSRVANY | 56 | O75688 | |
| AYLYIDEAHSIGAVG | 331 | Q9NUV7 | |
| GAHLTGVSIYYGTIL | 281 | Q8NGG2 | |
| GDFILGYYSHNHSIL | 816 | Q15735 | |
| GYYSHNHSILIGITE | 821 | Q15735 | |
| NSNAASGLYTIYLHG | 1076 | Q9UQP3 | |
| FITHGGANGIYEAIY | 371 | P06133 | |
| SGGVVLTAYHSYARA | 6 | Q9P2N2 | |
| FSLDYQVITGGHYDV | 51 | Q9Y3Q3 | |
| DFIPGTSGYLAYHVQ | 191 | Q8NHR7 | |
| DHLAEYLGANSVVYL | 446 | Q06203 | |
| YTGRAVLYVLGAVTH | 316 | Q86WB7 | |
| SGALQGYEVLHALGY | 571 | C9JH25 | |
| VYHASAYLDLVSQGF | 481 | Q8IYQ7 | |
| VSGEIYIGGQEHFYL | 731 | P47989 | |
| NHFYAAILGYDEGIL | 206 | Q9NVA1 | |
| VLAVHGAGNLVNTYY | 91 | Q9Y5Z9 | |
| FITHGGANGIYEAIY | 371 | O75310 | |
| SISYLAYQGAGFVHN | 1431 | Q4KWH8 | |
| YVDQAAGTPLLYVHA | 41 | P07949 | |
| LSTIGESNYHFGVTY | 121 | O96008 | |
| GHIAFYNGTDESLIY | 416 | Q8N9V2 | |
| ALSSLGHVYTAIGDY | 316 | Q96AY4 | |
| DVTLENYSHLLSVGY | 96 | P51814 | |
| GIFDSVSVQVGYEHY | 26 | Q14656 | |
| YEYDLIGVTVHTGTA | 2146 | Q70CQ2 | |
| AYINASGEHGIVVFS | 291 | P19224 | |
| FITHGGANGIYEAIY | 371 | Q9BY64 | |
| FITHGGANGIYEAIY | 371 | P16662 | |
| DAYSGGAVNLYHVRE | 226 | P28074 | |
| VAGGGVSVYYSHVLQ | 2106 | Q5T4S7 | |
| GGSYVYELSAVLIHR | 331 | Q86UV5 | |
| NIAVTLYLAATGHYN | 241 | Q15849 | |
| SAIGNVTGELVYAHY | 236 | Q9UP52 | |
| YLLLEGHCYDITTGQ | 1111 | Q9NYU2 | |
| IAALVHYSGVIFYGV | 486 | Q8NDX2 | |
| LAISTYAAYIGGYVH | 86 | Q96IK0 | |
| AYLAVNAAGGVEVYS | 171 | Q96A05 | |
| LYYVGHSQGTTIAFI | 166 | Q5VXJ0 | |
| QVLHLYGATYSADGE | 661 | P59046 | |
| HYAGEVTYSVTGFLD | 546 | O00159 | |
| RHYAGDVVYSVIGFI | 506 | O94832 |